Diligence memo · auto-generated · as of July 2, 2026

Evanostics, LLC

Evanostics, LLC looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Evanostics, LLC operates in Other Health Care, based in LOS GATOS.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Evanostics, LLC has raised $1.3M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $600K on 2020-10-23.

Most recent recorded round closed around 2021-03-04.

Valuation (modeled)modeled

Provath models Evanostics, LLC at approximately $10M (range $296K–$96M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.28× the median modeled value of Pre-Seed Other Health Care companies in 2019–2021 (295 peers) — value vs value, same stage and era. Within the normal band (128% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 6 months.

Last raise 5.3 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 4.7× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 39% of Other Health Care peers (5377 compared).

Modeled value ranks above 35% of those peers.

Closest niche peers: Aetas Co LLC, Hauppauge SC Holdings, LLC, Gateway IV Lithotripsy, LLC, Endoscopy Center of West Central Ohio, LLC, Dalent LLC.

Peoplefiled

3 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.